Form 4: BridgeBio Pharma CFO Reports Stock Transaction
Insider Transaction (Form 4)
Thomas Trimarchi, President and CFO of BridgeBio Pharma, Inc., reported a transaction in 22,781 shares of common stock on August 16, 2026.
Summary
- Tax/exercise-price withholding: disposed of 22,781 Common Stock at $79.86 ($1,819,291) on August 16, 2026; holds 336,529 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Thomas Trimarchi — Officer (President and CFO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-16 | Tax/exercise-price withholding | Common Stock | 22,781 | $80 | $1.8M | 336,529 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-16 | Tax/exercise-price withholding (22,781 shares) |
Keywords
insider transaction, Form 4, BBIO, BridgeBio Pharma, Inc., neutral, Thomas Trimarchi
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.